Gelmon K - Search Results

1

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†.

Cardoso F, Costa A, Norton L, Senkus E, Aapro M, André F, Barrios CH, Bergh J, Biganzoli L, Blackwell KL, Cardoso MJ, Cufer T, El Saghir N, Fallowfield L, Fenech D, Francis P, Gelmon K, Giordano SH, Gligorov J, Goldhirsch A, Harbeck N, Houssami N, Hudis C, Kaufman B, Krop I, Kyriakides S, Lin UN, Mayer M, Merjaver SD, Nordström EB, Pagani O, Partridge A, Penault-Llorca F, Piccart MJ, Rugo H, Sledge G, Thomssen C, Van't Veer L, Vorobiof D, Vrieling C, West N, Xu B, Winer E. Cardoso F, et al. Among authors: gelmon k. Ann Oncol. 2014 Oct;25(10):1871-1888. doi: 10.1093/annonc/mdu385. Epub 2014 Sep 18. Ann Oncol. 2014. PMID: 25234545 Free PMC article. No abstract available.

2

Efficacy of weekly cisplatin-based chemotherapy in recurrent and metastatic head and neck cancer.

Osoba D, Band PR, Goldie JH, Connors JM, Gelmon K, Knowling MA, Fetherstonhaugh EM. Osoba D, et al. Among authors: gelmon k. Ann Oncol. 1992 Aug;3 Suppl 3:57-62. doi: 10.1093/annonc/3.suppl_3.s57. Ann Oncol. 1992. PMID: 1390318

3

Phase I/II trial of biweekly paclitaxel and cisplatin in the treatment of metastatic breast cancer.

Gelmon KA, O'Reilly SE, Tolcher AW, Campbell C, Bryce C, Ragaz J, Coppin C, Plenderleith IH, Ayers D, McDermott B, Nakashima L, Healey D, Onetto N. Gelmon KA, et al. J Clin Oncol. 1996 Apr;14(4):1185-91. doi: 10.1200/JCO.1996.14.4.1185. J Clin Oncol. 1996. PMID: 8648373 Clinical Trial.

4

A phase I-II study of bi-weekly paclitaxel as first-line treatment in metastatic breast cancer.

Gelmon KA, Tolcher A, O'Reilly S, Campbell C, Bryce C, Shenkier T, Ragaz J, Ayers D, Nakashima L, Rielly S, Dulude H. Gelmon KA, et al. Ann Oncol. 1998 Nov;9(11):1247-9. doi: 10.1023/a:1008445123416. Ann Oncol. 1998. PMID: 9862057 Free article. Clinical Trial.

5

Randomized phase II study of BR96-doxorubicin conjugate in patients with metastatic breast cancer.

Tolcher AW, Sugarman S, Gelmon KA, Cohen R, Saleh M, Isaacs C, Young L, Healey D, Onetto N, Slichenmyer W. Tolcher AW, et al. Among authors: gelmon ka. J Clin Oncol. 1999 Feb;17(2):478-84. doi: 10.1200/JCO.1999.17.2.478. J Clin Oncol. 1999. PMID: 10080588 Clinical Trial.

6

A phase II study of ZD0473 given as a short infusion every 3 weeks to patients with advanced or metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group trial, IND 129.

Gelmon KA, Vandenberg TA, Panasci L, Norris B, Crump M, Douglas L, Walsh W, Matthews SJ, Seymour LK. Gelmon KA, et al. Ann Oncol. 2003 Apr;14(4):543-8. doi: 10.1093/annonc/mdg171. Ann Oncol. 2003. PMID: 12649098 Free article. Clinical Trial.

7

A phase I study of OSI-211 and cisplatin as intravenous infusions given on days 1, 2 and 3 every 3 weeks in patients with solid cancers.

MacKenzie MJ, Hirte HW, Siu LL, Gelmon K, Ptaszynski M, Fisher B, Eisenhauer E. MacKenzie MJ, et al. Among authors: gelmon k. Ann Oncol. 2004 Apr;15(4):665-70. doi: 10.1093/annonc/mdh133. Ann Oncol. 2004. PMID: 15033677 Free article. Clinical Trial.

8

A phase I study of AMD473 and docetaxel given once every 3 weeks in patients with advanced refractory cancer: a National Cancer Institute of Canada-Clinical Trials Group trial, IND 131.

Gelmon KA, Stewart D, Chi KN, Chia S, Cripps C, Huan S, Janke S, Ayers D, Fry D, Shabbits JA, Walsh W, McIntosh L, Seymour LK. Gelmon KA, et al. Ann Oncol. 2004 Jul;15(7):1115-22. doi: 10.1093/annonc/mdh278. Ann Oncol. 2004. PMID: 15205207 Free article. Clinical Trial.

9

Late risk of relapse and mortality among postmenopausal women with estrogen responsive early breast cancer after 5 years of tamoxifen.

Kennecke HF, Olivotto IA, Speers C, Norris B, Chia SK, Bryce C, Gelmon KA. Kennecke HF, et al. Among authors: gelmon ka. Ann Oncol. 2007 Jan;18(1):45-51. doi: 10.1093/annonc/mdl334. Epub 2006 Oct 9. Ann Oncol. 2007. PMID: 17030545 Free article.

10

Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial.

Perez EA, Suman VJ, Davidson NE, Sledge GW, Kaufman PA, Hudis CA, Martino S, Gralow JR, Dakhil SR, Ingle JN, Winer EP, Gelmon KA, Gersh BJ, Jaffe AS, Rodeheffer RJ. Perez EA, et al. J Clin Oncol. 2008 Mar 10;26(8):1231-8. doi: 10.1200/JCO.2007.13.5467. Epub 2008 Feb 4. J Clin Oncol. 2008. PMID: 18250349 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

367 results

Search Page